Coloplast Logo

Coloplast

Develops medical devices and services for people with intimate healthcare needs.

COLO | CO

Overview

Corporate Details

ISIN(s):
DK0060448595 (+1 more)
LEI:
529900NN7SOJ5QG82X67
Country:
Denmark
Address:
Holtedam 1, 3050 Humlebaek
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Coloplast is a global company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its mission is to make life easier for users by providing innovative solutions tailored to their needs. The company's primary business areas include Ostomy Care, Continence Care, Interventional Urology, and Advanced Wound & Skin Care. In addition to physical products, Coloplast provides comprehensive support services. 'Coloplast Care' offers practical and emotional support to patients, while 'Coloplast Professional' provides education, tools, and resources for healthcare providers to support their work and deepen their expertise.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 07:59
Management Discussion and Analysis
English 8.2 KB
2025-09-02 07:59
ISS
English 154.9 KB
2025-09-02 07:59
Management Discussion and Analysis
Danish 8.6 KB
2025-09-02 07:59
ISS
Danish 138.9 KB
2025-05-08 14:42
Director's Dealing
English 1.1 KB
2025-05-08 14:42
Director's Dealing
English 262.7 KB
2025-05-08 14:42
Director's Dealing
English 262.3 KB
2025-05-08 14:42
Director's Dealing
Norwegian 1.1 KB
2025-05-06 07:29
Earnings Release
English 1.1 MB
2025-05-06 07:29
Interim Report
Danish 656.2 KB
2025-05-06 07:29
Earnings Release
Danish 11.7 KB
2025-05-06 07:29
Earnings Release
English 10.5 KB
2025-05-05 17:11
Report Publication Announcement
English 114.6 KB
2025-05-05 17:11
Board/Management Information
English 5.0 KB
2025-05-01 12:23
Earnings Release
English 133.6 KB

Automate Your Workflow. Get a real-time feed of all Coloplast filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Coloplast via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AuBEX CORPORATION Logo
High-precision manufacturer of nibs for stationery, cosmetics, and medical infusion technology.
Japan 3583
Audientes A/S Logo
Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.
Denmark AUDNTS
Bactiguard Holding Logo
Licenses a patented coating to MedTech partners to prevent medical device infections.
Sweden BACTI
BBS-Bioactive Bone Substitutes Oyj Logo
Developed a bioactive bone graft substitute for orthopedic surgery before filing for bankruptcy.
Finland BONE
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom BELL
BENO TNR, Inc. Logo
A diversified firm in biotech, wearable robotics, and eco-friendly building materials.
South Korea 206400
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden BIBB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea 489460
Biocartis Group NV Logo
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium BCART
Biocorp Logo
Develops and manufactures connected drug delivery systems and medical devices for pharma.
France ALCOR

Talk to a Data Expert

Have a question? We'll get back to you promptly.